Loading clinical trials...
Loading clinical trials...
Uncovering Clinical Trial Engagement Among Individuals With Borderline Personality Disorder
Conditions
Locations
1
United States
Power Life Sciences
San Francisco, California, United States
Start Date
September 1, 2024
Primary Completion Date
September 1, 2025
Completion Date
September 1, 2026
Last Updated
August 14, 2023
NCT07342907
NCT05913544
NCT04852744
NCT06195553
NCT06563466
NCT02387736
Lead Sponsor
Power Life Sciences Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions